Sector Chart Alterity Therapeutics Limited Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
20:30:00 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2.234 USD | +2.93% |
|
+3.88% | -27.48% |
| 10-05 | Alterity Therapeutics Limited Presents New Analyses of Ath434 Phase 2 Data in Multiple System Atrophy | CI |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 64.38B | |||||
| 56.16B | |||||
| 54.16B | |||||
| 45.33B | |||||
| 42.25B |
Select your edition
All financial news and data tailored to specific country editions
